Two recent enforcement exercises by the Food and Drugs Authority (FDA) have strengthened public confidence in the agency’s ability to safeguard health. In August 2024, after extensive surveillance, the FDA imposed GH¢457,000 in fines on 19 entertainment facilities in Accra and Kasoa for permitting smoking indoors, which exposes patrons to second-hand smoke. This action, highlighting lesser-known regulations, sent a clear message that public health would not be compromised.
A month later, the FDA closed down four Osu-based supermarkets for selling unregistered Chinese-labelled drugs and tobacco products, violating the Public Health Act, 2012 (Act 851). The supermarkets were fined GH¢25,000 each, and investigations continue to trace the sources of the illegal goods, potentially implicating public officials.
While these efforts are commendable, the FDA must intensify efforts to combat the widespread peddling of expired and unregistered drugs in markets and transport hubs. The Authority should also raise public awareness about the dangers of using unapproved herbal medications. Establishing hotlines for reporting illegal activities could further enhance the FDA’s ability to protect public health.